Certain A Shares of R&G PharmaStudies Co., Ltd. are subject to a Lock-Up Agreement Ending on 3-AUG-2023. These A Shares will be under lockup for 373 days starting from 26-JUL-2022 to 3-AUG-2023.

Details:
Holding shareholder Ace Union Holding Ltd. commits within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.

Actual controllers Wu Jie and Zheng Hong Bei commits within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months. During the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company.

Shareholder Shihezi Kaihong Equity Investment Limited Partnership Enterprise commits within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.

Brother of Zheng Hongbei Zheng Honghui (partner of Shihezi Kaihong Equity Investment Limited Partnership Enterprise) commits within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.

Members of the board of directors, members of supervisory board, senior management personnel with indirect shareholding Li Shuqi, Teng Leyan, Wang Wei, Guan Hong, Zhang Weiguo, Zheng Yan, Cheng Gang and Zhao Qian commits if the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months. During the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company. Within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.

Shareholders Shihezi Kangyunfu Equity Investment Co., Ltd. and Shihezi Ruiguang Equity Investment Limited Partnership commits within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.

Shareholder Shihezi Ruiming Equity Investment Co., Ltd. commits within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.

Shareholder Hexie Growth Phase 2 (Yiwu) Investment Center (L.P.) commits within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.

Shareholders Zhuhai Hexie Health Investment Fund (L.P.), Jifeng Jike (Shanghai) Investment Management Center (Limited Partnership), Beijing Legend Yikang Equity Investment Partnership Enterprise (L.P.), Suzhou Jifeng Equity Investment Partnership (Limited Partnership), Fuzhou Jifeng Equity Investment Partnership (Limited Partnership), Shenzhen Capital Group Co., Ltd., Beijing Huimei Kangyuan Management Consulting Partnership Enterprise (Limited Partnership), Shenzhen Nanshan Hongtu Equity Investment Fund Partnership Enterprise (Limited Partnership), Shenzhen Hongtu Medical Healthcare Industry Equity Investment Fund Partnership Enterprise (L.P.) and Zhuhai Gaoling Ciheng Equity Investment Partnership Enterprise (Limited Partnership) commits within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.